首页> 外文期刊>Pediatric Pulmonology >Effects of maternal retinoic acid administration in a congenital diaphragmatic hernia rabbit model.
【24h】

Effects of maternal retinoic acid administration in a congenital diaphragmatic hernia rabbit model.

机译:母体维甲酸在先天性diaphragm肌疝兔模型中的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Maternal retinoid administration has beneficial effects on lung development in the nitrofen rodent toxic model of congenital diaphragmatic hernia (DH). We wanted to investigate the effects in a surgical model, where the retinoid signaling pathway is not primarily disrupted by the toxic agent. We created DH in fetal rabbits at day 23 of gestation, administrated to the does all trans-retinoic acid (ATRA) or vehicle (VHC) intramuscularly for 8 consecutive days and harvested normal and operated (DH) fetuses at 31 d (n = 7 in each group). Normal lungs exposed to ATRA had increased surfactant protein mRNA levels without change in type II pneumocyte density. There was no measurable effect on lung-to-body weight ratio and airway morphometry by ATRA. In DH lungs (DH/VHC) surfactant protein mRNA levels were increased, as well as the density of type II pneumocytes. When supplemented with ATRA (DH/ATRA) these parameters returned to normal (VHC). Cell proliferation or apoptosis were not influenced by ATRA supplementation. In conclusion, maternal ATRA supplementation does not affect gross anatomic, morphologic or proliferation indices in hypoplastic lungs related to surgically induced DH in rabbit. However, ATRA lowers surfactant protein expression and normalizes type I/II pneumocyte ratio to what is observed in normal lungs.
机译:在先天性diaphragm肌疝(DH)的硝苯芬啮齿动物毒性模型中,母体类维生素A给药对肺部发育具有有益作用。我们想研究一种手术模型中的作用,在该模型中类维生素A信号传导途径并未主要被有毒物质破坏。我们在妊娠第23天在胎兔中创建了DH,连续8天对所有反式维甲酸(ATRA)或媒介物(VHC)进行了给药,并在31 d收集了正常和手术(DH)胎儿在每个组中)。暴露于ATRA的正常肺的表面活性剂蛋白mRNA水平增加,而II型肺细胞密度没有变化。 ATRA对肺体重比和气道形态没有明显影响。在DH肺(DH / VHC)中,表面活性剂蛋白的mRNA水平以及II型肺细胞的密度均升高。当补充了ATRA(DH / ATRA)时,这些参数恢复为正常(VHC)。细胞增殖或凋亡不受ATRA补充的影响。总之,母体ATRA补充剂不会影响与手术诱发的DH相关的增生性肺的总体解剖,形态或增殖指数。但是,ATRA降低了表面活性剂蛋白的表达,并使I / II型肺细胞比例正常化为正常肺中的水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号